Clinical Trials Browser

OTHER × bemarituzumab × Clear all

NCT06967987 2026-01-21

BEMAFLOT

Phase 2 Withdrawn

Adenocarcinoma

NCT07146919 2025-08-28

ANGELICA

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT02213289 2021-04-08

PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

Phase 2 Completed

80 enrolled 14 charts

Adenocarcinoma